Found 51 matching trials
Endostar Combination With Chemotherapy and EGFR-TKI in Lung Cancer Rechallenging Treatment After Acquired Resistance. PHASE2 Here we are going to find a method by using available multiple drugs includ...
Show More Location
Peking University Third Hospital
Learn More & Join Trial
A Phase 2 Study of Tomudex & Iressa as Second Line Chemotherapy in Subjects With Colorectal Carcinoma PHASE2 The primary objective of this study is to compare the activity of raltitrex...
Show More Learn More & Join Trial
Evaluating Preventive Therapy With Oint Threolone, Synthomycine or Aqua Cream, for EGFR'I Induced Acneiform Rash PHASE2 The investigators hypothesized that topical anti-inflammatory treatment cou...
Show More Location
Davidoff Center, Rabin Medical Center, Beilinson
Learn More & Join Trial
Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa Study PHASE2 This study is being carried out to see if ZD1839 is effective in treating m...
Show More Learn More & Join Trial
Phase II Trial of Preoperative Therapy With Gefitinib and Chemotherapy in Patients With ERneg Breast Cancer PHASE2 The aim of the study is to estimate the effect of preoperative gefitinib on...
Show More Learn More & Join Trial
Open Label Extension Study With Gefitinib (IRESSA™) for Completing Trial Patients Who May Benefit From Further Treatment N/A The purpose of this study is to provide gefitinib treatment to patients who...
Show More Status
Approved For Marketing
Learn More & Join Trial
ZD 1839 Plus Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer PHASE3 RATIONALE: Some tumors need growth factors produced by the body's white blo...
Show More Location
AstraZeneca Pharmaceuticals LP
Learn More & Join Trial
JY025 is a First-line Treatment for EGFR Mutated NSCLC Phase II and III Clinical Trials of Efficacy and Safety PHASE2 The Phase II study is a multi-center, open, dose escalation and dose extens...
Show More Location
Multiple Locations
Learn More & Join Trial
Assess the Efficacy, Safety and Tolerability of Gefitinib (Iressa® 250mg) as Maintenance Therapy in Locally Advanced or Metastatic (Stage IIIB/IV) Non Small Cell Lung Cancer (NSCLC) PHASE4 This is a double blind, multicentre, randomized, placebo-controlled study. ...
Show More Learn More & Join Trial
Clinical Study of Chinese Medicine Plus Targeted Therapy Maintenance in Advanced Pulmonary Adenocarcinoma PHASE3 The investigators performed a randomized, double blind controlled, prospect...
Show More Location
Multiple Locations
Learn More & Join Trial